Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity. Issue 22 (15th November 2015)

• Record Type: Journal Article
• Authors: Anami, Yasuaki; Sakamaki, Yuta; Itoh, Toshimasa; Inaba, Yuka; Nakabayashi, Makoto; Ikura, Teikichi; Ito, Nobutoshi; Yamamoto, Keiko
• Is Part Of: Bioorganic & medicinal chemistry. Volume 23:Issue 22(2015)
• Page Start: 7274
• Page End: 7281
• Publication Date: 2015-11-15
• Subjects: VDR vitamin D receptor -- LBD ligand-binding domain -- 1α, 25-(OH)2D3 1α, 25-dihydroxyvitamin D3 -- SERM selective estrogen receptor modulator -- ERα estrogen receptor α -- PPARγ peroxisome proliferator-activated receptor γ; Vitamin D -- Nuclear receptor -- X-ray crystallographic structure -- Ligand-binding pocket -- Partial agonist; Bioorganic chemistry -- Periodicals; Pharmaceutical chemistry -- Periodicals; Biochemistry -- Periodicals; Chemistry, Clinical -- Periodicals; Chemistry, Organic -- Periodicals; Chimie bio-organique -- Périodiques; Chimie pharmaceutique -- Périodiques; 615.19
• DOI: 10.1016/j.bmc.2015.10.026
• Languages: English
• ISSNs: 0968-0896

Abstract

Graphical abstract: Abstract: 1α, 25-Dihydroxyvitamin D3 exerts its actions by binding to vitamin D receptor (VDR). We are continuing the study related to the alteration of pocket structure of VDR by 22-alkyl substituent of ligands and the relationships between the alteration and agonistic/antagonistic activity. Previously we reported that compounds2 (22-H), 3 (22 S -Et), and4 (22 S -Bu) are VDR agonist, partial agonist and antagonist, respectively. Here, we describe the synthesis and biological evaluation of 22 S -hexyl analog5 (22 S -Hex), which was designed to be a stronger VDR antagonist than4 . Unexpectedly, 5 showed partial agonistic but not antagonistic activity when bound to VDR, indicating that it is not necessarily true that the bulkier the side chain is, the stronger the antagonistic activity will be. X-ray crystallographic analysis of the VDR–ligand-binding domain (VDR–LBD) accommodating compound5 indicated that the partial agonist activity of5 is dependent on the mixed population of the agonistic and antagonistic conformations. Binding of compound5 may not bring the complex into the only antagonistic conformation due to the large conformational change of the VDR–LBD. From this study it was found that fine tuning of agonistic/antagonistic activity for VDR is possible by 22-alkyl chain length of ligands.